vs

Side-by-side financial comparison of BLACKBERRY Ltd (BB) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

BLACKBERRY Ltd is the larger business by last-quarter revenue ($141.8M vs $75.5M, roughly 1.9× PUMA BIOTECHNOLOGY, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -0.8%). BLACKBERRY Ltd produced more free cash flow last quarter ($17.4M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 17.8%).

BlackBerry Limited, formerly Research In Motion (RIM), is a Canadian software company specializing in secure communications and the Internet of Things (IoT). Founded in 1984, it developed the BlackBerry brand of two-way pagers, smartphones, and tablets. The company later transitioned to providing software and services and holds critical software application patents.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

BB vs PBYI — Head-to-Head

Bigger by revenue
BB
BB
1.9× larger
BB
$141.8M
$75.5M
PBYI
Growing faster (revenue YoY)
PBYI
PBYI
+28.6% gap
PBYI
27.7%
-0.8%
BB
More free cash flow
BB
BB
$3.0M more FCF
BB
$17.4M
$14.4M
PBYI
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
17.8%
BB

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
BB
BB
PBYI
PBYI
Revenue
$141.8M
$75.5M
Net Profit
$13.7M
Gross Margin
77.5%
69.3%
Operating Margin
8.4%
22.7%
Net Margin
9.7%
Revenue YoY
-0.8%
27.7%
Net Profit YoY
224.5%
EPS (diluted)
$0.02
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BB
BB
PBYI
PBYI
Q4 25
$141.8M
$75.5M
Q3 25
$129.6M
$54.5M
Q2 25
$121.7M
$52.4M
Q1 25
$141.7M
$46.0M
Q4 24
$143.6M
$59.1M
Q3 24
$126.2M
$80.5M
Q2 24
$123.4M
$47.1M
Q1 24
$102.1M
$43.8M
Net Profit
BB
BB
PBYI
PBYI
Q4 25
$13.7M
Q3 25
$13.3M
$8.8M
Q2 25
$1.9M
$5.9M
Q1 25
$-7.4M
$3.0M
Q4 24
$-10.5M
Q3 24
$-19.7M
$20.3M
Q2 24
$-41.4M
$-4.5M
Q1 24
$-56.2M
$-4.8M
Gross Margin
BB
BB
PBYI
PBYI
Q4 25
77.5%
69.3%
Q3 25
74.5%
77.7%
Q2 25
74.2%
76.5%
Q1 25
73.5%
77.1%
Q4 24
78.1%
76.4%
Q3 24
70.2%
63.9%
Q2 24
72.9%
77.4%
Q1 24
75.5%
Operating Margin
BB
BB
PBYI
PBYI
Q4 25
8.4%
22.7%
Q3 25
8.9%
17.6%
Q2 25
1.6%
12.7%
Q1 25
-5.6%
8.7%
Q4 24
13.6%
22.6%
Q3 24
1.7%
27.4%
Q2 24
-10.5%
-4.6%
Q1 24
50.0%
-5.3%
Net Margin
BB
BB
PBYI
PBYI
Q4 25
9.7%
Q3 25
10.3%
16.2%
Q2 25
1.6%
11.2%
Q1 25
-5.2%
6.5%
Q4 24
-7.3%
Q3 24
-15.6%
25.2%
Q2 24
-33.5%
-9.6%
Q1 24
-55.0%
-11.0%
EPS (diluted)
BB
BB
PBYI
PBYI
Q4 25
$0.02
$0.26
Q3 25
$0.02
$0.17
Q2 25
$0.00
$0.12
Q1 25
$-0.01
$0.06
Q4 24
$-0.02
$0.40
Q3 24
$-0.03
$0.41
Q2 24
$-0.07
$-0.09
Q1 24
$-0.08
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BB
BB
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$304.2M
$97.5M
Total DebtLower is stronger
$196.2M
$22.7M
Stockholders' EquityBook value
$741.1M
$130.3M
Total Assets
$1.2B
$216.3M
Debt / EquityLower = less leverage
0.26×
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BB
BB
PBYI
PBYI
Q4 25
$304.2M
$97.5M
Q3 25
$290.5M
$94.4M
Q2 25
$306.6M
$96.0M
Q1 25
$337.8M
$93.2M
Q4 24
$220.0M
$101.0M
Q3 24
$211.0M
$96.7M
Q2 24
$229.0M
$96.8M
Q1 24
$237.1M
$107.2M
Total Debt
BB
BB
PBYI
PBYI
Q4 25
$196.2M
$22.7M
Q3 25
$195.9M
$34.0M
Q2 25
$195.6M
$45.3M
Q1 25
$195.3M
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$194.1M
$102.0M
Stockholders' Equity
BB
BB
PBYI
PBYI
Q4 25
$741.1M
$130.3M
Q3 25
$725.1M
$115.3M
Q2 25
$725.1M
$104.7M
Q1 25
$719.9M
$97.1M
Q4 24
$725.2M
$92.1M
Q3 24
$732.1M
$71.1M
Q2 24
$742.6M
$48.5M
Q1 24
$775.1M
$51.0M
Total Assets
BB
BB
PBYI
PBYI
Q4 25
$1.2B
$216.3M
Q3 25
$1.2B
$202.9M
Q2 25
$1.2B
$194.9M
Q1 25
$1.3B
$196.2M
Q4 24
$1.3B
$213.3M
Q3 24
$1.3B
$220.7M
Q2 24
$1.3B
$205.0M
Q1 24
$1.4B
$214.1M
Debt / Equity
BB
BB
PBYI
PBYI
Q4 25
0.26×
0.17×
Q3 25
0.27×
0.30×
Q2 25
0.27×
0.43×
Q1 25
0.27×
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
0.25×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BB
BB
PBYI
PBYI
Operating Cash FlowLast quarter
$18.3M
$14.4M
Free Cash FlowOCF − Capex
$17.4M
$14.4M
FCF MarginFCF / Revenue
12.3%
19.1%
Capex IntensityCapex / Revenue
0.6%
0.0%
Cash ConversionOCF / Net Profit
1.34×
TTM Free Cash FlowTrailing 4 quarters
$42.8M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BB
BB
PBYI
PBYI
Q4 25
$18.3M
$14.4M
Q3 25
$3.9M
$9.7M
Q2 25
$-18.0M
$14.1M
Q1 25
$41.6M
$3.6M
Q4 24
$6.0M
$15.6M
Q3 24
$-16.0M
$11.0M
Q2 24
$-15.1M
$1.0M
Q1 24
$-15.5M
$11.2M
Free Cash Flow
BB
BB
PBYI
PBYI
Q4 25
$17.4M
$14.4M
Q3 25
$3.1M
$9.7M
Q2 25
$-18.9M
$14.1M
Q1 25
$41.2M
$3.6M
Q4 24
$5.2M
$15.6M
Q3 24
$-16.5M
$11.0M
Q2 24
$-16.5M
$1.0M
Q1 24
$-17.6M
FCF Margin
BB
BB
PBYI
PBYI
Q4 25
12.3%
19.1%
Q3 25
2.4%
17.7%
Q2 25
-15.5%
26.8%
Q1 25
29.1%
7.7%
Q4 24
3.6%
26.4%
Q3 24
-13.1%
13.7%
Q2 24
-13.4%
2.1%
Q1 24
-17.2%
Capex Intensity
BB
BB
PBYI
PBYI
Q4 25
0.6%
0.0%
Q3 25
0.6%
0.0%
Q2 25
0.7%
0.0%
Q1 25
0.3%
0.1%
Q4 24
0.6%
0.0%
Q3 24
0.4%
0.0%
Q2 24
1.1%
0.0%
Q1 24
2.1%
0.0%
Cash Conversion
BB
BB
PBYI
PBYI
Q4 25
1.34×
Q3 25
0.29×
1.10×
Q2 25
-9.47×
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BB
BB

QNX$68.7M48%
Secure Communication$67.0M47%
Licensing$6.1M4%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons